Trastuzumab-deruxtecan in breast cancer treatment: Balancing the triad of efficacy, safety and accessibility
- PMID: 40928857
- DOI: 10.47102/annals-acadmedsg.2025229
Trastuzumab-deruxtecan in breast cancer treatment: Balancing the triad of efficacy, safety and accessibility
Keywords: cancer; internal medicine; oncology; pharmacology; public health.
Conflict of interest statement
The authors declare there are no affiliations with or involvement in any organisation or entity with any financial interest in the subject matter or materials discussed in this manuscript.
Publication types
LinkOut - more resources
Full Text Sources